Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhiya Yu

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Cancer Research|July 22, 2010
Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hostsSid P Kerkar, Pawel Muranski, Andrew Kaiser, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2008
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunityDouglas C Palmer, Chi-Chao Chan, Luca Gattinoni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancerNachimuthu Chinnasamy, Jennifer A Wargo, Zhiya Yu, et al.
Journal of Leukocyte Biology|May 25, 2004
Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancerSteven E Finkelstein, David M Heimann, Christopher A Klebanoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2014
miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokinesYun Ji, Claudia Wrzesinski, Zhiya Yu, et al.
Nature Medicine|September 20, 2011
A human memory T cell subset with stem cell-like propertiesLuca Gattinoni, Enrico Lugli, Yun Ji, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunityChristian S Hinrichs, Zachary A Borman, Lydie Cassard, et al.
BMC Cancer|October 21, 2011
Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68Maria Libera Ascierto, Andrea Worschech, Zhiya Yu, et al.
Cell|August 28, 2016
Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic NicheDavid Clever, Rahul Roychoudhuri, Michael G Constantinides, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Identification and Validation of T-cell Receptors Targeting <i>RAS</i> Hotspot Mutations in Human Cancers for Use in Cell-based ImmunotherapyNoam Levin, Biman C Paria, Nolan R Vale, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Cancer Research|July 22, 2010
Tumor-specific CD8+ T cells expressing interleukin-12 eradicate established cancers in lymphodepleted hostsSid P Kerkar, Pawel Muranski, Andrew Kaiser, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2008
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunityDouglas C Palmer, Chi-Chao Chan, Luca Gattinoni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 2010
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancerNachimuthu Chinnasamy, Jennifer A Wargo, Zhiya Yu, et al.
Journal of Leukocyte Biology|May 25, 2004
Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancerSteven E Finkelstein, David M Heimann, Christopher A Klebanoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2014
miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokinesYun Ji, Claudia Wrzesinski, Zhiya Yu, et al.
Nature Medicine|September 20, 2011
A human memory T cell subset with stem cell-like propertiesLuca Gattinoni, Enrico Lugli, Yun Ji, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunityChristian S Hinrichs, Zachary A Borman, Lydie Cassard, et al.
BMC Cancer|October 21, 2011
Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68Maria Libera Ascierto, Andrea Worschech, Zhiya Yu, et al.
Cell|August 28, 2016
Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic NicheDavid Clever, Rahul Roychoudhuri, Michael G Constantinides, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Identification and Validation of T-cell Receptors Targeting <i>RAS</i> Hotspot Mutations in Human Cancers for Use in Cell-based ImmunotherapyNoam Levin, Biman C Paria, Nolan R Vale, et al.
Pageof 9